89 related articles for article (PubMed ID: 1369312)
1. New pyrrolobenzodiazepine antibiotics, RK-1441A and B. I. Biological properties.
Osada H; Ishinabe K; Yano T; Kajikawa K; Isono K
Agric Biol Chem; 1990 Nov; 54(11):2875-81. PubMed ID: 1369312
[TBL] [Abstract][Full Text] [Related]
2. New pyrrolobenzodiazepine antibiotics, RK-1441A and B. II. Isolation and structure.
Osada H; Uramoto M; Uzawa J; Kajikawa K; Isono K
Agric Biol Chem; 1990 Nov; 54(11):2883-7. PubMed ID: 1368648
[TBL] [Abstract][Full Text] [Related]
3. Caboxamycin, a new antibiotic of the benzoxazole family produced by the deep-sea strain Streptomyces sp. NTK 937.
Hohmann C; Schneider K; Bruntner C; Irran E; Nicholson G; Bull AT; Jones AL; Brown R; Stach JE; Goodfellow M; Beil W; Krämer M; Imhoff JF; Süssmuth RD; Fiedler HP
J Antibiot (Tokyo); 2009 Feb; 62(2):99-104. PubMed ID: 19198633
[TBL] [Abstract][Full Text] [Related]
4. [Use of the method of phage induction for the isolation and purification of antitumor antibiotics].
Gauze GF; Terekhova LP; Kudinova MK; Rossolimo OK; Ukholina RS; Kovsharova IN; Nechaeva NP
Antibiotiki; 1967 Mar; 12(3):179-83. PubMed ID: 4874765
[No Abstract] [Full Text] [Related]
5. Preliminary studies on a Streptomyces sp. CS-14 showing broad spectrum antibiotic activity.
Malviya HK; Golwalkar MP; Narayanan MS; Tandon GD
Hindustan Antibiot Bull; 1994; 36(1-2):21-9. PubMed ID: 7737893
[TBL] [Abstract][Full Text] [Related]
6. Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. I: taxonomy, fermentation, isolation and biological properties.
Iwatsuki M; Uchida R; Yoshijima H; Ui H; Shiomi K; Matsumoto A; Takahashi Y; Abe A; Tomoda H; Omura S
J Antibiot (Tokyo); 2008 Apr; 61(4):222-9. PubMed ID: 18503201
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.
Anizon F; Belin L; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T
J Med Chem; 1997 Oct; 40(21):3456-65. PubMed ID: 9341921
[TBL] [Abstract][Full Text] [Related]
8. UCH9, a new antitumor antibiotic produced by Streptomyces: I. Producing organism, fermentation, isolation and biological activities.
Ogawa H; Yamashita Y; Katahira R; Chiba S; Iwasaki T; Ashizawa T; Nakano H
J Antibiot (Tokyo); 1998 Mar; 51(3):261-6. PubMed ID: 9589060
[TBL] [Abstract][Full Text] [Related]
9. [Search for antibiotic antimetabolites].
Gauze GF
Antibiotiki; 1976 Jan; 21(1):3-5. PubMed ID: 776066
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and permeability of the anthramycin producing organism Streptomyces refuineus to anthramycin and structurally related antibiotics.
Rokem JS; Hurley LH
J Antibiot (Tokyo); 1981 Sep; 34(9):1171-4. PubMed ID: 6895748
[TBL] [Abstract][Full Text] [Related]
11. Pyrrolo(1,4)benzodiazepine antitumor antibiotics. Comparative aspects of anthramycin, tomaymycin and sibiromycin.
Hurley LH
J Antibiot (Tokyo); 1977 May; 30(5):349-70. PubMed ID: 328469
[No Abstract] [Full Text] [Related]
12. Novel antitumor antibiotics, saptomycins. I. Taxonomy of the producing organism, fermentation, HPLC analysis and biological activities.
Abe N; Nakakita Y; Nakamura T; Enoki N; Uchida H; Munekata M
J Antibiot (Tokyo); 1993 Oct; 46(10):1530-5. PubMed ID: 8244880
[TBL] [Abstract][Full Text] [Related]
13. U-43,120; a new antitumor antibiotic. I. Production, biological activity, microbiological assay and taxonomy of the producing microorganism.
Hanka LJ; Dietz A
J Antibiot (Tokyo); 1976 Jun; 29(6):611-7. PubMed ID: 950315
[TBL] [Abstract][Full Text] [Related]
14. Terpentecin and ECT4B, new family of topoisomerase II targeting antitumor antibiotics produced by Streptomyces: producing organism, fermentation and large scale purification.
Kawada S; Yamashita Y; Ochiai K; Ando K; Iwasaki T; Takiguchi T; Nakano H
J Antibiot (Tokyo); 1995 Mar; 48(3):211-6. PubMed ID: 7730154
[TBL] [Abstract][Full Text] [Related]
15. UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. I. Fermentation, isolation, and biological properties.
Ueki M; Abe K; Hanafi M; Shibata K; Tanaka T; Taniguchi M
J Antibiot (Tokyo); 1996 Jul; 49(7):639-43. PubMed ID: 8784423
[TBL] [Abstract][Full Text] [Related]
16. Thrazarine, a new antitumor antibiotic. I. Taxonomy, fermentation, isolation and biological properties.
Kameyama T; Takahashi A; Matsumoto H; Kurasawa S; Hamada M; Okami Y; Ishizuka M; Takeuchi T
J Antibiot (Tokyo); 1988 Nov; 41(11):1561-7. PubMed ID: 3143704
[TBL] [Abstract][Full Text] [Related]
17. Production of new hybrid antibiotics, mederrhodins A and B, by a genetically engineered strain.
Omura S; Ikeda H; Malpartida F; Kieser HM; Hopwood DA
Antimicrob Agents Chemother; 1986 Jan; 29(1):13-9. PubMed ID: 3460518
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of a new class of pyrazolo[4,3-e]pyrrolo[1,2-a][1,4]diazepinone analogues of pyrrolo[1,4][2,1-c]benzodiazepines.
Baraldi PG; Leoni A; Cacciari B; Manfredini S; Simoni D; Bergomi M; Menta E; Spinelli S
J Med Chem; 1994 Dec; 37(25):4329-37. PubMed ID: 7996544
[TBL] [Abstract][Full Text] [Related]
19. In vitro methods used in detection and quantitation of antitumor drugs produced by microbial fermentations.
Hanka LJ; Martin DG; Neil GL
Lloydia; 1978; 41(2):85-97. PubMed ID: 651563
[No Abstract] [Full Text] [Related]
20. Variation in the inhibition of restriction enzyme cleavage of lambda phage DNA produced by two covalent binding antitumor agents: anthramycin and mitomycin C.
Kaplan DJ
Biochem Biophys Res Commun; 1982 Dec; 109(3):639-48. PubMed ID: 6297483
[No Abstract] [Full Text] [Related]
[Next] [New Search]
